A Hidden Reservoir of Methicillin-resistant Staphylococcus aureus and Vancomycin-resistant Enterococcus in Patients Newly Admitted to an Acute Rehabilitation Hospital

被引:10
|
作者
Rabinowitz, Ronald P. [1 ]
Kufera, Joseph A. [2 ]
Makley, Michael J. [3 ,4 ]
机构
[1] Univ Maryland, Sch Med, Div Infect Dis, Baltimore, MD 21201 USA
[2] Univ Maryland, Sch Med, Shock Trauma & Anesthesiol Res Organized Res Ctr, Charles McC Mathias Natl Study Ctr Trauma & EMS, Baltimore, MD 21201 USA
[3] Univ Maryland, Sch Med, Dept Neurol, Baltimore, MD 21201 USA
[4] Keman Orthopaed Rehabil Hosp, Traumat Brain Injury Unit, Baltimore, MD USA
关键词
COMMUNITY-ACQUIRED PNEUMONIA; INFECTIOUS-DISEASES-SOCIETY; ANTIMICROBIAL RESISTANCE; RISK-FACTORS; INTENSIVE-CARE; UNITED-STATES; COLONIZATION; ORGANISMS; TRENDS; EPIDEMIOLOGY;
D O I
10.1016/j.pmrj.2011.09.011
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
Objective: To find hidden reservoirs of methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE) via active surveillance cultures for MRSA and VRE in newly admitted patients. Design: A prospective, cohort, screening study. The period of surveillance was 3 months in the winter of 2006-2007. Setting: A freestanding academic and community rehabilitation hospital. Participants: A total of 540 consecutive patients admitted to a freestanding rehabilitation hospital. Methods: All of the patients were screened for MRSA and VRE upon admission to the hospital. Main Outcome Measure: The number of new patients identified with either MRSA or VRE colonization. Results: A total of 540 patients were screened, of whom 42 (7.8%) had pre-existing MRSA status, 8(1.5%) had pre-existing VRE status, and 10(1.9%) had a history of positive results for both MRSA and VRE. Of the 480 patients without pre-existing positive cultures, admission swabs were positive for MRSA in 37 patients (7.7%), swabs were positive for VRE in 33 patients (6.9%), and swabs for both MRSA and VRE were newly positive for 7 patients (1.5%). Therefore 16% of the patients without a history of MRSA or VRE had a new finding of MRSA or VRE. Regression analysis revealed that prior bacteremia was a risk factor for MRSA; diabetes mellitus and a history of pneumonia and trimethoprim-sulfamethoxazole use were risk factors for VRE. Conclusion: We found a 16% incidence of a hidden reservoir of multiple drug-resistant organisms in patients admitted to rehabilitation hospitals. We believe that all patients admitted to a rehabilitation facility should be screened for MRSA and VRE. PM R 2012;4:18-22
引用
收藏
页码:18 / 22
页数:5
相关论文
共 50 条
  • [31] Independent risk factors for the co-colonization of vancomycin-resistant Enterococcus faecalis and methicillin-resistant Staphylococcus aureus in the region most endemic for vancomycin-resistant Staphylococcus aureus isolation
    Hayakawa, K.
    Marchaim, D.
    Bathina, P.
    Martin, E. T.
    Pogue, J. M.
    Sunkara, B.
    Kamatam, S.
    Ho, K.
    Willis, L. B.
    Ajamoughli, M.
    Patel, D.
    Khan, A.
    Lee, K. P.
    Suhrawardy, U.
    Jagadeesh, K. K.
    Reddy, S. M. L.
    Levine, M.
    Ahmed, F.
    Omotola, A. M.
    Mustapha, M.
    Moshos, J. A.
    Rybak, M. J.
    Kaye, K. S.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2013, 32 (06) : 815 - 820
  • [32] Prediction rules to identify patients with methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci upon hospital admission
    Furuno, JP
    Harris, AD
    Wright, MO
    McGregor, JC
    Venezia, RA
    Zhu, JK
    Perencevich, EN
    AMERICAN JOURNAL OF INFECTION CONTROL, 2004, 32 (08) : 436 - 440
  • [33] Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: Therapeutic realities and possibilities
    Michel, M
    Gutmann, L
    LANCET, 1997, 349 (9069): : 1901 - 1906
  • [34] Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci co-colonization
    Furuno, JP
    Perencevich, EN
    Johnson, JA
    Wright, MO
    McGregor, JC
    Morris, JG
    Strauss, SM
    Roghman, MC
    Nemoy, LL
    Standiford, HC
    Hebden, JN
    Harris, AD
    EMERGING INFECTIOUS DISEASES, 2005, 11 (10) : 1539 - 1544
  • [35] Natural history of colonization with methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus(VRE): a systematic review
    Erica S Shenoy
    Molly L Paras
    Farzad Noubary
    Rochelle P Walensky
    David C Hooper
    BMC Infectious Diseases, 14
  • [36] Unrecognized Burden of Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococcus Carriage in the Pediatric Intensive Care Unit
    Milstone, Aaron M.
    Song, Xiaoyan
    Beers, Claire
    Berkowitz, Ivor
    Carroll, Karen C.
    Perl, Trish M.
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2008, 29 (12): : 1174 - 1176
  • [37] Linezolid for methicillin-resistant Staphylococcus aureus or vancomycin-resistant Enterococcus infection: meta-analysis of randomized trials
    Martin, J.
    Sawh, S.
    Newman, J.
    Deshpande, S.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2009, 34 : S24 - S24
  • [38] Natural history of colonization with methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE): a systematic review
    Shenoy, Erica S.
    Paras, Molly L.
    Noubary, Farzad
    Walensky, Rochelle P.
    Hooper, David C.
    BMC INFECTIOUS DISEASES, 2014, 14
  • [39] Methicillin-resistant Staphylococcus aureus, Vancomycin-resistant Enterococcus faecalis and Enterococcus faecium active Dimeric Isobutyrylphloroglucinol from Ivesia gordonii
    Ahmed, Marwa H.
    Ibrahim, Mohamed Ali
    Zhang, Jin
    Melek, Farouk R.
    El-Hawary, Seham S.
    Jacob, Melissa R.
    Muhammad, Ilias
    NATURAL PRODUCT COMMUNICATIONS, 2014, 9 (02) : 221 - 224
  • [40] Sitafloxacin in the treatment of patients with infections caused by vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus
    Shetty, N
    Wilson, APR
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 46 (04) : 633 - 637